

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.44452533 |
| 2 | vitamin A metabolic process (GO:0006776) | 8.25504341 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.68622448 |
| 4 | hormone catabolic process (GO:0042447) | 6.55606737 |
| 5 | phospholipid efflux (GO:0033700) | 6.38988729 |
| 6 | virion attachment to host cell (GO:0019062) | 6.21821020 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 6.21821020 |
| 8 | actin filament depolymerization (GO:0030042) | 6.09846788 |
| 9 | regulation of cholesterol esterification (GO:0010872) | 6.06949756 |
| 10 | positive regulation of triglyceride lipase activity (GO:0061365) | 6.06309100 |
| 11 | positive regulation of lipoprotein lipase activity (GO:0051006) | 6.06309100 |
| 12 | flavonoid metabolic process (GO:0009812) | 6.04414864 |
| 13 | plasma lipoprotein particle assembly (GO:0034377) | 5.90086909 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 5.88731886 |
| 15 | protein-lipid complex assembly (GO:0065005) | 5.64375316 |
| 16 | drug catabolic process (GO:0042737) | 5.60109264 |
| 17 | bile acid and bile salt transport (GO:0015721) | 5.55805079 |
| 18 | cholesterol efflux (GO:0033344) | 5.50590202 |
| 19 | peptide hormone processing (GO:0016486) | 5.29037770 |
| 20 | digestive system process (GO:0022600) | 5.28920145 |
| 21 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.18232691 |
| 22 | lipoprotein metabolic process (GO:0042157) | 5.16152803 |
| 23 | peptide catabolic process (GO:0043171) | 5.15244218 |
| 24 | regulation of guanylate cyclase activity (GO:0031282) | 5.11019288 |
| 25 | lipoprotein transport (GO:0042953) | 5.07570566 |
| 26 | oligosaccharide catabolic process (GO:0009313) | 5.05114867 |
| 27 | adhesion of symbiont to host (GO:0044406) | 5.03811681 |
| 28 | glucose 6-phosphate metabolic process (GO:0051156) | 5.02790320 |
| 29 | negative regulation of lipase activity (GO:0060192) | 4.87515240 |
| 30 | modified amino acid transport (GO:0072337) | 4.70119374 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.64780875 |
| 32 | cellular glucuronidation (GO:0052695) | 4.55695916 |
| 33 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.54468299 |
| 34 | glucuronate metabolic process (GO:0019585) | 4.53679322 |
| 35 | uronic acid metabolic process (GO:0006063) | 4.53679322 |
| 36 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.52107117 |
| 37 | regulation of bile acid biosynthetic process (GO:0070857) | 4.49818767 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.48698427 |
| 39 | regulation of triglyceride metabolic process (GO:0090207) | 4.46669990 |
| 40 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.46053769 |
| 41 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.46053769 |
| 42 | response to hepatocyte growth factor (GO:0035728) | 4.41546308 |
| 43 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.41546308 |
| 44 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.39080524 |
| 45 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.35626298 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.35106300 |
| 47 | sterol transport (GO:0015918) | 4.34225787 |
| 48 | cholesterol transport (GO:0030301) | 4.34225787 |
| 49 | cholesterol homeostasis (GO:0042632) | 4.32894882 |
| 50 | drinking behavior (GO:0042756) | 4.32514722 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.28721342 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.28721342 |
| 53 | diacylglycerol metabolic process (GO:0046339) | 4.28312282 |
| 54 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.27298907 |
| 55 | sterol homeostasis (GO:0055092) | 4.27101010 |
| 56 | vitamin D metabolic process (GO:0042359) | 4.22444995 |
| 57 | nucleobase catabolic process (GO:0046113) | 4.15986292 |
| 58 | heme transport (GO:0015886) | 4.13165486 |
| 59 | sphingomyelin metabolic process (GO:0006684) | 4.11455146 |
| 60 | fat-soluble vitamin metabolic process (GO:0006775) | 4.08417212 |
| 61 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.07471767 |
| 62 | * digestion (GO:0007586) | 4.02878265 |
| 63 | homocysteine metabolic process (GO:0050667) | 4.02086666 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95510416 |
| 65 | L-ascorbic acid metabolic process (GO:0019852) | 3.85155824 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 3.82477066 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 3.82477066 |
| 68 | macromolecular complex remodeling (GO:0034367) | 3.82477066 |
| 69 | regulation of protein glycosylation (GO:0060049) | 3.82361678 |
| 70 | cellular carbohydrate catabolic process (GO:0044275) | 3.76150695 |
| 71 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.75907508 |
| 72 | endocrine process (GO:0050886) | 3.75907508 |
| 73 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.75907508 |
| 74 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.75870456 |
| 75 | acylglycerol homeostasis (GO:0055090) | 3.68888593 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.68888593 |
| 77 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.68013007 |
| 78 | cellular response to oxygen radical (GO:0071450) | 3.66514236 |
| 79 | removal of superoxide radicals (GO:0019430) | 3.66514236 |
| 80 | cellular response to superoxide (GO:0071451) | 3.66514236 |
| 81 | plasma lipoprotein particle organization (GO:0071827) | 3.63880568 |
| 82 | protein-lipid complex subunit organization (GO:0071825) | 3.63545214 |
| 83 | sulfate transmembrane transport (GO:1902358) | 3.62425155 |
| 84 | cellular response to nitric oxide (GO:0071732) | 3.61055754 |
| 85 | regulation of lipoprotein metabolic process (GO:0050746) | 3.60268453 |
| 86 | bile acid metabolic process (GO:0008206) | 3.53080780 |
| 87 | phenylpropanoid metabolic process (GO:0009698) | 3.52565597 |
| 88 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.52083555 |
| 89 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.50724113 |
| 90 | cellular response to zinc ion (GO:0071294) | 3.49692305 |
| 91 | NADH metabolic process (GO:0006734) | 3.49206227 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.41835441 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.41016837 |
| 94 | fructose metabolic process (GO:0006000) | 3.40163311 |
| 95 | negative regulation of digestive system process (GO:0060457) | 3.39973141 |
| 96 | response to hydroperoxide (GO:0033194) | 3.38864774 |
| 97 | regulation of systemic arterial blood pressure (GO:0003073) | 3.38196000 |
| 98 | positive regulation of p38MAPK cascade (GO:1900745) | 3.37516175 |
| 99 | retinoid metabolic process (GO:0001523) | 3.33259956 |
| 100 | purine nucleotide salvage (GO:0032261) | 3.31628701 |
| 101 | regulation of digestive system process (GO:0044058) | 3.29807037 |
| 102 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.28850323 |
| 103 | regulation of lipoprotein particle clearance (GO:0010984) | 3.22780390 |
| 104 | protein kinase C signaling (GO:0070528) | 3.18672176 |
| 105 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.17552175 |
| 106 | alkaloid metabolic process (GO:0009820) | 3.16488316 |
| 107 | bicarbonate transport (GO:0015701) | 3.15838693 |
| 108 | ovulation from ovarian follicle (GO:0001542) | 3.15469460 |
| 109 | sulfur compound transport (GO:0072348) | 3.15086704 |
| 110 | polyol transport (GO:0015791) | 3.14386132 |
| 111 | response to phenylpropanoid (GO:0080184) | 3.14294374 |
| 112 | regulation of actin nucleation (GO:0051125) | 3.13818669 |
| 113 | cellular response to reactive nitrogen species (GO:1902170) | 3.12663241 |
| 114 | diterpenoid metabolic process (GO:0016101) | 3.11282235 |
| 115 | transepithelial transport (GO:0070633) | 3.11174218 |
| 116 | regulation of lipid catabolic process (GO:0050994) | 3.11113595 |
| 117 | regulation of cholesterol transport (GO:0032374) | 3.10546998 |
| 118 | regulation of sterol transport (GO:0032371) | 3.10546998 |
| 119 | cGMP biosynthetic process (GO:0006182) | 3.10470288 |
| 120 | drug transport (GO:0015893) | 3.07118320 |
| 121 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.06811707 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.05332750 |
| 123 | negative regulation of sodium ion transport (GO:0010766) | 3.04542597 |
| 124 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.98882112 |
| 125 | sulfate transport (GO:0008272) | 2.97705698 |
| 126 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.96957269 |
| 127 | omega-hydroxylase P450 pathway (GO:0097267) | 2.95076337 |
| 128 | lipid homeostasis (GO:0055088) | 2.94765674 |
| 129 | cellular anion homeostasis (GO:0030002) | 2.89717841 |
| 130 | drug metabolic process (GO:0017144) | 2.87396277 |
| 131 | sulfation (GO:0051923) | 2.85556023 |
| 132 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85390218 |
| 133 | exogenous drug catabolic process (GO:0042738) | 2.83639336 |
| 134 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.83020358 |
| 135 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.82626711 |
| 136 | glycerol metabolic process (GO:0006071) | 2.81651472 |
| 137 | angiotensin maturation (GO:0002003) | 13.2883622 |
| 138 | intestinal cholesterol absorption (GO:0030299) | 12.7798195 |
| 139 | intestinal absorption (GO:0050892) | 12.4859071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.32703173 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.12801817 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.18707552 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.09989924 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.77712857 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61070230 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.48907465 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47568326 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47131960 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41447620 |
| 11 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.18792796 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17690799 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16125562 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.13689397 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.11547814 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.99289537 |
| 17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.93598964 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88476928 |
| 19 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.85640950 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84052900 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81634490 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78627077 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76818714 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72247557 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68201098 |
| 26 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.68110456 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.65934767 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65664769 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65612976 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64934221 |
| 31 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.55750077 |
| 32 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.54918374 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51394345 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.49067456 |
| 35 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.43850282 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43783083 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43578201 |
| 38 | GATA2_19941826_ChIP-Seq_K562_Human | 1.42879432 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42089201 |
| 40 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40790410 |
| 41 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.38516006 |
| 42 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.35719276 |
| 43 | RXR_22108803_ChIP-Seq_LS180_Human | 1.35366623 |
| 44 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35300972 |
| 45 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34680489 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33543021 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33504398 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31798558 |
| 49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30400813 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30013604 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29294159 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27520876 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26302493 |
| 54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23928767 |
| 55 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.22857186 |
| 56 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.22728527 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22175917 |
| 58 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.21393855 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19897410 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18223379 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18223379 |
| 62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17846526 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17833166 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15640112 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15152959 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14604175 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14528317 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12819567 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11000693 |
| 70 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.10245044 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09807867 |
| 72 | CBP_21632823_ChIP-Seq_H3396_Human | 1.08666220 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08351467 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08196260 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08170335 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07728260 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07690714 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07130300 |
| 79 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06857169 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06612701 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05866324 |
| 82 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05599508 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05021052 |
| 84 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04725209 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04651276 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02841250 |
| 87 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.02382896 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02068189 |
| 89 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00944184 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00882670 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00145718 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98583996 |
| 93 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.98039430 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97312125 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96897936 |
| 96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96234682 |
| 97 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95658436 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95295806 |
| 99 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.94464270 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94166519 |
| 101 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94137518 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92769396 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91461154 |
| 104 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90738304 |
| 105 | * SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.89274507 |
| 106 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.89055550 |
| 107 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88786335 |
| 108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88147598 |
| 109 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87097785 |
| 110 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87009871 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86927149 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86311110 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85247152 |
| 114 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84790104 |
| 115 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.84771235 |
| 116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84705841 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83764785 |
| 118 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.82036748 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81098376 |
| 120 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.80277271 |
| 121 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80218832 |
| 122 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79953749 |
| 123 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.79569708 |
| 124 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79440359 |
| 125 | SPI1_23127762_ChIP-Seq_K562_Human | 0.78271283 |
| 126 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.78269190 |
| 127 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76880450 |
| 128 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.76672975 |
| 129 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.76672975 |
| 130 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.75663099 |
| 131 | NFYA_21822215_ChIP-Seq_K562_Human | 0.75193218 |
| 132 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.74881729 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.74705039 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74571726 |
| 135 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74571726 |
| 136 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.74413331 |
| 137 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74231675 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73387415 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72594355 |
| 140 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72448490 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72004146 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71423846 |
| 143 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.70952214 |
| 144 | KDM2B_26808549_Chip-Seq_K562_Human | 0.70296222 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.69710168 |
| 146 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69544740 |
| 147 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.68735221 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.68712086 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68451444 |
| 150 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.68384070 |
| 151 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.68174885 |
| 152 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.68054242 |
| 153 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67821027 |
| 154 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.66762689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.70361213 |
| 2 | MP0001666_abnormal_nutrient_absorption | 6.88127572 |
| 3 | MP0009840_abnormal_foam_cell | 4.97364720 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.46623391 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.02863396 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.82127980 |
| 7 | MP0003252_abnormal_bile_duct | 3.30515778 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.16867111 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.02737521 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.00795058 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.87743352 |
| 12 | MP0000462_abnormal_digestive_system | 2.72531136 |
| 13 | MP0002822_catalepsy | 2.71445291 |
| 14 | MP0003866_abnormal_defecation | 2.47488283 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.19971295 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.14776061 |
| 17 | MP0004043_abnormal_pH_regulation | 2.13715586 |
| 18 | MP0004147_increased_porphyrin_level | 1.96960358 |
| 19 | MP0002876_abnormal_thyroid_physiology | 1.84649395 |
| 20 | MP0005448_abnormal_energy_balance | 1.69337907 |
| 21 | MP0004270_analgesia | 1.67462598 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 1.66880025 |
| 23 | MP0003878_abnormal_ear_physiology | 1.66880025 |
| 24 | MP0001664_abnormal_digestion | 1.63515867 |
| 25 | MP0002254_reproductive_system_inflammat | 1.54946471 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.49486898 |
| 27 | MP0005409_darkened_coat_color | 1.49084490 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.48661991 |
| 29 | MP0005381_digestive/alimentary_phenotyp | 1.45238067 |
| 30 | MP0005365_abnormal_bile_salt | 1.41390936 |
| 31 | MP0000537_abnormal_urethra_morphology | 1.36772246 |
| 32 | MP0001663_abnormal_digestive_system | 1.35726066 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.34269784 |
| 34 | MP0009697_abnormal_copulation | 1.30097599 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.29853828 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.29678015 |
| 37 | MP0002796_impaired_skin_barrier | 1.27846537 |
| 38 | MP0003868_abnormal_feces_composition | 1.27651647 |
| 39 | MP0005670_abnormal_white_adipose | 1.23467777 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.22941516 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.20404154 |
| 42 | MP0000477_abnormal_intestine_morphology | 1.19433491 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.15836517 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.15552230 |
| 45 | MP0001873_stomach_inflammation | 1.14666507 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.13408048 |
| 47 | MP0005332_abnormal_amino_acid | 1.10137681 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.08384056 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.05853996 |
| 50 | MP0009053_abnormal_anal_canal | 0.93944762 |
| 51 | MP0008872_abnormal_physiological_respon | 0.91515175 |
| 52 | MP0000609_abnormal_liver_physiology | 0.91337950 |
| 53 | MP0009765_abnormal_xenobiotic_induced | 0.91019300 |
| 54 | MP0001764_abnormal_homeostasis | 0.89998217 |
| 55 | MP0006054_spinal_hemorrhage | 0.89409293 |
| 56 | MP0005535_abnormal_body_temperature | 0.89355917 |
| 57 | MP0003283_abnormal_digestive_organ | 0.89003807 |
| 58 | MP0000467_abnormal_esophagus_morphology | 0.87875681 |
| 59 | MP0003879_abnormal_hair_cell | 0.85118305 |
| 60 | MP0005166_decreased_susceptibility_to | 0.84654315 |
| 61 | MP0009643_abnormal_urine_homeostasis | 0.84452791 |
| 62 | MP0000490_abnormal_crypts_of | 0.84355780 |
| 63 | MP0000604_amyloidosis | 0.83575887 |
| 64 | MP0004947_skin_inflammation | 0.83462093 |
| 65 | MP0009379_abnormal_foot_pigmentation | 0.83319764 |
| 66 | MP0003718_maternal_effect | 0.82101916 |
| 67 | MP0001849_ear_inflammation | 0.82024498 |
| 68 | MP0001188_hyperpigmentation | 0.81436057 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.79798096 |
| 70 | MP0005266_abnormal_metabolism | 0.77495555 |
| 71 | MP0010678_abnormal_skin_adnexa | 0.74604939 |
| 72 | MP0001765_abnormal_ion_homeostasis | 0.73042566 |
| 73 | MP0001756_abnormal_urination | 0.72400118 |
| 74 | MP0000249_abnormal_blood_vessel | 0.72250512 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.71353284 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.69957058 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.68984176 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.68897383 |
| 79 | MP0000678_abnormal_parathyroid_gland | 0.68689365 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.67953564 |
| 81 | MP0005501_abnormal_skin_physiology | 0.64088343 |
| 82 | MP0003953_abnormal_hormone_level | 0.60974640 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.60116436 |
| 84 | MP0002098_abnormal_vibrissa_morphology | 0.59944834 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.59527771 |
| 86 | MP0005395_other_phenotype | 0.59380873 |
| 87 | MP0006138_congestive_heart_failure | 0.59352418 |
| 88 | MP0000516_abnormal_urinary_system | 0.59166002 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 0.59166002 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56630635 |
| 91 | MP0008469_abnormal_protein_level | 0.53068505 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.52309812 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.51892623 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.51523276 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.51162626 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.51068939 |
| 97 | MP0009764_decreased_sensitivity_to | 0.49934559 |
| 98 | MP0009115_abnormal_fat_cell | 0.49923778 |
| 99 | MP0006082_CNS_inflammation | 0.49181537 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.48389493 |
| 101 | MP0004145_abnormal_muscle_electrophysio | 0.48299520 |
| 102 | MP0003329_amyloid_beta_deposits | 0.47492954 |
| 103 | MP0000427_abnormal_hair_cycle | 0.47252419 |
| 104 | MP0001440_abnormal_grooming_behavior | 0.47152958 |
| 105 | MP0001881_abnormal_mammary_gland | 0.45276923 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.44292070 |
| 107 | MP0001919_abnormal_reproductive_system | 0.43150572 |
| 108 | MP0001191_abnormal_skin_condition | 0.42396836 |
| 109 | MP0005451_abnormal_body_composition | 0.41662600 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.41399139 |
| 111 | MP0003136_yellow_coat_color | 0.41385196 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.41223482 |
| 113 | MP0003119_abnormal_digestive_system | 0.40849156 |
| 114 | MP0005334_abnormal_fat_pad | 0.40420122 |
| 115 | MP0000579_abnormal_nail_morphology | 0.40112892 |
| 116 | MP0003385_abnormal_body_wall | 0.39937284 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.39679601 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.39505242 |
| 119 | MP0002971_abnormal_brown_adipose | 0.38880618 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.38548993 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.37598266 |
| 122 | MP0000598_abnormal_liver_morphology | 0.36490222 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.36331206 |
| 124 | MP0004885_abnormal_endolymph | 0.36264442 |
| 125 | MP0002734_abnormal_mechanical_nocicepti | 0.35822000 |
| 126 | MP0000534_abnormal_ureter_morphology | 0.34148679 |
| 127 | MP0002135_abnormal_kidney_morphology | 0.31437099 |
| 128 | MP0000566_synostosis | 0.31185750 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.30763537 |
| 130 | MP0002909_abnormal_adrenal_gland | 0.29004501 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.26984140 |
| 132 | MP0005410_abnormal_fertilization | 0.25405185 |
| 133 | MP0005389_reproductive_system_phenotype | 0.24540122 |
| 134 | MP0004142_abnormal_muscle_tone | 0.24394892 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.24239317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acanthocytosis (HP:0001927) | 8.84093274 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 8.81931793 |
| 3 | Ileus (HP:0002595) | 8.26265462 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.63997524 |
| 5 | Malnutrition (HP:0004395) | 6.40168862 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 6.07815215 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 5.97852361 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.72194284 |
| 9 | Widely patent fontanelles and sutures (HP:0004492) | 5.71326101 |
| 10 | Abnormality of proline metabolism (HP:0010907) | 5.66823984 |
| 11 | Hydroxyprolinuria (HP:0003080) | 5.66823984 |
| 12 | Facial shape deformation (HP:0011334) | 5.26543779 |
| 13 | Potter facies (HP:0002009) | 5.26543779 |
| 14 | Pigmentary retinal degeneration (HP:0001146) | 5.11554523 |
| 15 | Poikilocytosis (HP:0004447) | 5.07721428 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.97728042 |
| 17 | Fat malabsorption (HP:0002630) | 4.51261682 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 4.42210485 |
| 19 | Cupped ribs (HP:0000887) | 4.41103838 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 4.28802604 |
| 21 | Increased IgE level (HP:0003212) | 3.97150747 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83541916 |
| 23 | Decreased circulating renin level (HP:0003351) | 3.77754684 |
| 24 | Xanthomatosis (HP:0000991) | 3.68332359 |
| 25 | Wide cranial sutures (HP:0010537) | 3.64730373 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.61411049 |
| 27 | Proximal tubulopathy (HP:0000114) | 3.56916447 |
| 28 | Steatorrhea (HP:0002570) | 3.48992545 |
| 29 | Hyperglycinuria (HP:0003108) | 3.36766510 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.26661791 |
| 31 | Abnormality of magnesium homeostasis (HP:0004921) | 3.26522048 |
| 32 | Mesangial abnormality (HP:0001966) | 3.20880459 |
| 33 | Hyperammonemia (HP:0001987) | 3.19505830 |
| 34 | Chronic diarrhea (HP:0002028) | 3.14352664 |
| 35 | Abdominal distention (HP:0003270) | 3.12849458 |
| 36 | Epidermoid cyst (HP:0200040) | 3.10734011 |
| 37 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.02935329 |
| 38 | Hypomagnesemia (HP:0002917) | 3.01191118 |
| 39 | Gastrointestinal dysmotility (HP:0002579) | 2.99110985 |
| 40 | Increased mean platelet volume (HP:0011877) | 2.97503442 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.94397760 |
| 42 | Reticulocytosis (HP:0001923) | 2.93575196 |
| 43 | Abnormality of B cell number (HP:0010975) | 2.88105485 |
| 44 | B lymphocytopenia (HP:0010976) | 2.88105485 |
| 45 | Alkalosis (HP:0001948) | 2.85969531 |
| 46 | Hypoproteinemia (HP:0003075) | 2.85393097 |
| 47 | Abnormality of vitamin B metabolism (HP:0004340) | 2.81877921 |
| 48 | Tetany (HP:0001281) | 2.79996207 |
| 49 | Glycosuria (HP:0003076) | 2.79394625 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.79394625 |
| 51 | Progressive sensorineural hearing impairment (HP:0000408) | 2.78249041 |
| 52 | Nephrolithiasis (HP:0000787) | 2.77226796 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 2.75606944 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.73923921 |
| 55 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.71328161 |
| 56 | Abnormal glucose tolerance (HP:0001952) | 2.70670401 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.67333848 |
| 58 | Abnormal platelet volume (HP:0011876) | 2.64591351 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.63230968 |
| 60 | Confusion (HP:0001289) | 2.54846441 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.51781162 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.49746068 |
| 63 | Thyroiditis (HP:0100646) | 2.48779664 |
| 64 | Hyperglycinemia (HP:0002154) | 2.48693435 |
| 65 | Polycythemia (HP:0001901) | 2.48168796 |
| 66 | Abnormality of renin-angiotensin system (HP:0000847) | 2.43558669 |
| 67 | Combined immunodeficiency (HP:0005387) | 2.40709112 |
| 68 | Progressive hearing impairment (HP:0001730) | 2.40434596 |
| 69 | Abnormality of vitamin metabolism (HP:0100508) | 2.37227457 |
| 70 | Posterior subcapsular cataract (HP:0007787) | 2.36016799 |
| 71 | Spontaneous abortion (HP:0005268) | 2.33572631 |
| 72 | Abnormality of the gastric mucosa (HP:0004295) | 2.27755884 |
| 73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25197695 |
| 74 | Abnormality of glycine metabolism (HP:0010895) | 2.25197695 |
| 75 | Metabolic alkalosis (HP:0200114) | 2.18727782 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16494554 |
| 77 | Enlarged epiphyses (HP:0010580) | 2.15395668 |
| 78 | Hyperuricemia (HP:0002149) | 2.12736564 |
| 79 | Increased purine levels (HP:0004368) | 2.12736564 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.11302330 |
| 81 | Hyperphosphaturia (HP:0003109) | 2.08589962 |
| 82 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.07442678 |
| 83 | Villous atrophy (HP:0011473) | 2.07442678 |
| 84 | Abnormal platelet function (HP:0011869) | 2.05049827 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.05049827 |
| 86 | White forelock (HP:0002211) | 2.04132632 |
| 87 | Gingival bleeding (HP:0000225) | 2.03144891 |
| 88 | Subcapsular cataract (HP:0000523) | 2.01516603 |
| 89 | * Dehydration (HP:0001944) | 1.99110431 |
| 90 | Delayed CNS myelination (HP:0002188) | 1.98758239 |
| 91 | Hyperaldosteronism (HP:0000859) | 1.97820041 |
| 92 | Symptomatic seizures (HP:0011145) | 1.96710866 |
| 93 | Hypotension (HP:0002615) | 1.96315542 |
| 94 | Hyperkalemia (HP:0002153) | 1.95679058 |
| 95 | Syncope (HP:0001279) | 1.95523195 |
| 96 | Patchy hypopigmentation of hair (HP:0011365) | 1.94920241 |
| 97 | Urethral obstruction (HP:0000796) | 1.92745493 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92060466 |
| 99 | Abnormality of the costochondral junction (HP:0000919) | 1.91165856 |
| 100 | Alopecia of scalp (HP:0002293) | 1.90742101 |
| 101 | Generalized aminoaciduria (HP:0002909) | 1.90652042 |
| 102 | Hyperbilirubinemia (HP:0002904) | 1.89601333 |
| 103 | Flat acetabular roof (HP:0003180) | 1.89116329 |
| 104 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86869960 |
| 105 | Amyloidosis (HP:0011034) | 1.85863746 |
| 106 | Milia (HP:0001056) | 1.84555527 |
| 107 | Polygenic inheritance (HP:0010982) | 1.84383680 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.83447368 |
| 109 | Cholecystitis (HP:0001082) | 1.82830339 |
| 110 | Abnormal gallbladder physiology (HP:0012438) | 1.82830339 |
| 111 | Systemic lupus erythematosus (HP:0002725) | 1.82529491 |
| 112 | Joint hemorrhage (HP:0005261) | 1.81217557 |
| 113 | Osteomalacia (HP:0002749) | 1.80879326 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.79609180 |
| 115 | Hyperactive renin-angiotensin system (HP:0000841) | 1.79542418 |
| 116 | Thin bony cortex (HP:0002753) | 1.79415249 |
| 117 | Abnormal biliary tract morphology (HP:0012440) | 1.78932790 |
| 118 | Abnormality of the 1st metacarpal (HP:0010009) | 1.78150022 |
| 119 | Hypoalphalipoproteinemia (HP:0003233) | 1.76599667 |
| 120 | Abnormal urine phosphate concentration (HP:0012599) | 1.76373584 |
| 121 | Skin nodule (HP:0200036) | 1.75990215 |
| 122 | Peripheral demyelination (HP:0011096) | 1.75689009 |
| 123 | Increased serum ferritin (HP:0003281) | 1.73849571 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73649465 |
| 125 | Cheilitis (HP:0100825) | 1.72537928 |
| 126 | Pancreatitis (HP:0001733) | 1.70282730 |
| 127 | * Metabolic acidosis (HP:0001942) | 1.69788626 |
| 128 | Petechiae (HP:0000967) | 1.69441172 |
| 129 | Renal tubular dysfunction (HP:0000124) | 1.69261205 |
| 130 | Pili torti (HP:0003777) | 1.68977361 |
| 131 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.68650414 |
| 132 | Bundle branch block (HP:0011710) | 1.67866243 |
| 133 | Prolonged neonatal jaundice (HP:0006579) | 1.67323014 |
| 134 | Abnormality of chloride homeostasis (HP:0011422) | 1.67045442 |
| 135 | Hypophosphatemia (HP:0002148) | 1.66045281 |
| 136 | Irritability (HP:0000737) | 1.65966484 |
| 137 | Fragile skin (HP:0001030) | 1.64709705 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.64515269 |
| 139 | Abnormality of serum amino acid levels (HP:0003112) | 1.63594402 |
| 140 | Myopathic facies (HP:0002058) | 1.63571383 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.63234952 |
| 142 | Abnormality of potassium homeostasis (HP:0011042) | 1.62907949 |
| 143 | Joint swelling (HP:0001386) | 1.62683921 |
| 144 | Hypokalemia (HP:0002900) | 1.62317607 |
| 145 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.61551354 |
| 146 | Nausea (HP:0002018) | 1.61268167 |
| 147 | Abnormal albumin level (HP:0012116) | 1.60736320 |
| 148 | Hypoalbuminemia (HP:0003073) | 1.60736320 |
| 149 | Palpitations (HP:0001962) | 1.59542956 |
| 150 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.59166030 |
| 151 | Hypophosphatemic rickets (HP:0004912) | 1.58797759 |
| 152 | Abnormality of iron homeostasis (HP:0011031) | 1.56940018 |
| 153 | Dicarboxylic aciduria (HP:0003215) | 1.56251968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.19323929 |
| 2 | PIK3CG | 7.90010540 |
| 3 | MUSK | 6.83333857 |
| 4 | MST4 | 5.85250743 |
| 5 | FRK | 5.61930984 |
| 6 | AKT3 | 4.20335543 |
| 7 | GRK6 | 3.99450198 |
| 8 | NME1 | 3.96814202 |
| 9 | LMTK2 | 3.72441276 |
| 10 | MST1R | 3.60006124 |
| 11 | EPHA2 | 3.29903958 |
| 12 | PRKG2 | 3.15405778 |
| 13 | MAP3K10 | 3.04083090 |
| 14 | RIPK1 | 2.44521920 |
| 15 | PDK2 | 2.32595660 |
| 16 | NUAK1 | 2.20786710 |
| 17 | MAP3K2 | 2.19272585 |
| 18 | ERN1 | 1.88056145 |
| 19 | PTK6 | 1.77252968 |
| 20 | NLK | 1.65793234 |
| 21 | MAP2K2 | 1.60695221 |
| 22 | MAP3K9 | 1.56819242 |
| 23 | STK10 | 1.50315360 |
| 24 | RIPK4 | 1.49242979 |
| 25 | MAP3K7 | 1.37224575 |
| 26 | KSR2 | 1.35775961 |
| 27 | EPHA4 | 1.35089253 |
| 28 | BCKDK | 1.29684485 |
| 29 | DDR2 | 1.22985430 |
| 30 | STK39 | 1.22547403 |
| 31 | TAOK1 | 1.21317752 |
| 32 | EPHB2 | 1.19458020 |
| 33 | MET | 1.14720823 |
| 34 | TNIK | 1.13136844 |
| 35 | TESK2 | 1.08818507 |
| 36 | BMX | 1.06049349 |
| 37 | WNK3 | 1.05964859 |
| 38 | PRKCI | 1.02157222 |
| 39 | EPHB1 | 0.99171780 |
| 40 | TAOK3 | 0.98661906 |
| 41 | PIM1 | 0.96327490 |
| 42 | OXSR1 | 0.96015272 |
| 43 | MATK | 0.94804810 |
| 44 | MAP3K8 | 0.94601394 |
| 45 | PRKAA2 | 0.84167342 |
| 46 | FGFR2 | 0.84109408 |
| 47 | FER | 0.81385331 |
| 48 | NTRK3 | 0.80815443 |
| 49 | CDK12 | 0.78488310 |
| 50 | CASK | 0.77462534 |
| 51 | PTK2 | 0.76983476 |
| 52 | PBK | 0.75710125 |
| 53 | MAP3K1 | 0.74412481 |
| 54 | TESK1 | 0.70441390 |
| 55 | PDPK1 | 0.65202800 |
| 56 | TBK1 | 0.63627965 |
| 57 | BRSK2 | 0.63601212 |
| 58 | DMPK | 0.63352168 |
| 59 | LATS1 | 0.61528136 |
| 60 | ERBB2 | 0.61386324 |
| 61 | MAP3K11 | 0.61265938 |
| 62 | TTK | 0.61164020 |
| 63 | MAP2K6 | 0.60685574 |
| 64 | ICK | 0.57377446 |
| 65 | FGFR4 | 0.56978846 |
| 66 | BMPR1B | 0.54656840 |
| 67 | NEK9 | 0.54461647 |
| 68 | SCYL2 | 0.54058255 |
| 69 | ARAF | 0.51684835 |
| 70 | CDK5 | 0.51330291 |
| 71 | NEK6 | 0.50742397 |
| 72 | TEC | 0.50613605 |
| 73 | MAPK11 | 0.48394758 |
| 74 | PDK1 | 0.48085141 |
| 75 | PAK3 | 0.47177408 |
| 76 | TYK2 | 0.46710859 |
| 77 | IRAK1 | 0.45425103 |
| 78 | MAP2K1 | 0.43818200 |
| 79 | EPHA3 | 0.41684161 |
| 80 | ADRBK2 | 0.41600163 |
| 81 | CDK19 | 0.39216409 |
| 82 | BRAF | 0.38696336 |
| 83 | PTK2B | 0.38641639 |
| 84 | PRKCA | 0.36717468 |
| 85 | STK11 | 0.36060918 |
| 86 | FGR | 0.35524610 |
| 87 | JAK1 | 0.34883494 |
| 88 | MARK3 | 0.34338289 |
| 89 | PRKAA1 | 0.33548281 |
| 90 | ABL2 | 0.33503709 |
| 91 | KSR1 | 0.33495077 |
| 92 | FGFR3 | 0.32836112 |
| 93 | SYK | 0.32676586 |
| 94 | ITK | 0.32175160 |
| 95 | MYLK | 0.32073430 |
| 96 | STK24 | 0.31477428 |
| 97 | PAK4 | 0.31380815 |
| 98 | MARK2 | 0.31101847 |
| 99 | CAMK2B | 0.31048734 |
| 100 | TYRO3 | 0.30785808 |
| 101 | PRKD3 | 0.30614086 |
| 102 | PRKCE | 0.30049934 |
| 103 | SRC | 0.29812886 |
| 104 | FYN | 0.29639693 |
| 105 | IRAK2 | 0.29351237 |
| 106 | BRD4 | 0.27933393 |
| 107 | PRKCQ | 0.27791292 |
| 108 | MELK | 0.27467117 |
| 109 | INSRR | 0.26246008 |
| 110 | CSNK1A1 | 0.25891656 |
| 111 | RAF1 | 0.25879630 |
| 112 | PRKACB | 0.25712066 |
| 113 | PRKACG | 0.24714389 |
| 114 | MAP3K13 | 0.24349067 |
| 115 | MAP4K1 | 0.23501340 |
| 116 | WNK4 | 0.23185159 |
| 117 | MKNK2 | 0.23106627 |
| 118 | BTK | 0.23028276 |
| 119 | PAK2 | 0.22671064 |
| 120 | GRK1 | 0.22546622 |
| 121 | MAPK15 | 0.21564744 |
| 122 | DYRK1B | 0.20914001 |
| 123 | GRK5 | 0.20155077 |
| 124 | BMPR2 | 0.19930830 |
| 125 | MAP3K3 | 0.18251955 |
| 126 | MAP3K12 | 0.18236923 |
| 127 | CSK | 0.17898477 |
| 128 | PRKCD | 0.17498359 |
| 129 | AKT2 | 0.17203250 |
| 130 | LRRK2 | 0.17009555 |
| 131 | CSF1R | 0.16839560 |
| 132 | PRKACA | 0.16829902 |
| 133 | IRAK3 | 0.16707637 |
| 134 | PRKCB | 0.16170807 |
| 135 | PRKCG | 0.15890185 |
| 136 | OBSCN | 0.15692662 |
| 137 | RPS6KA3 | 0.15109293 |
| 138 | CDK6 | 0.15018465 |
| 139 | SGK3 | 0.14967648 |
| 140 | JAK2 | 0.14373412 |
| 141 | ROCK1 | 0.13467983 |
| 142 | ADRBK1 | 0.13150882 |
| 143 | PIM2 | 0.12793502 |
| 144 | CAMK2D | 0.12435311 |
| 145 | PRKCZ | 0.12211700 |
| 146 | CDK11A | 0.12033893 |
| 147 | ERBB4 | 0.11714654 |
| 148 | CAMK2A | 0.11596649 |
| 149 | TLK1 | 0.11086054 |
| 150 | PRKG1 | 0.10414911 |
| 151 | LYN | 0.09853963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.30661096 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.36333551 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 5.32937586 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.35972424 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.93374234 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 3.79341474 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.16035907 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.90584752 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.84295378 |
| 10 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.45957824 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.33890727 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.26397784 |
| 13 | * Galactose metabolism_Homo sapiens_hsa00052 | 2.11014509 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.05317065 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.89340645 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84839257 |
| 17 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.77019841 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.63603713 |
| 19 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.59104423 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.53565458 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50884856 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37562415 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34817113 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34134898 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26994053 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.19365958 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19308299 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12732631 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08086642 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.08062357 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05644148 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03590225 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03317848 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 0.92110844 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84648799 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79685223 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78615938 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78333539 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74981672 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71718667 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71482920 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67686382 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67575707 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66586911 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62595168 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62349129 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60179753 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56224904 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55567115 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54606855 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 0.52492050 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.51219841 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51018180 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50848470 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50032608 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47940854 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.47775409 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47386631 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.46970721 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46227598 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44915319 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42929176 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41791741 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40962381 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40336079 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39191002 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39142496 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37707902 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37585077 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36825274 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36589145 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33946062 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33652396 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31407156 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31180609 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.27164296 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27116407 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.26776716 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26773530 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26047464 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25746945 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23512473 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.22880496 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.22670283 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.21845155 |
| 86 | Long-term depression_Homo sapiens_hsa04730 | 0.19675504 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.19614146 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.19365825 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19361014 |
| 90 | Gap junction_Homo sapiens_hsa04540 | 0.18158296 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.15998456 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.15733803 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15446268 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14759675 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.14729778 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13882071 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.13673094 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13438284 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.12509723 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12465694 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.12251648 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.11863609 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11496988 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.11435093 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11150077 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.10465781 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10391253 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09554555 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.09485948 |
| 110 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.09117807 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.08966962 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.08925794 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.07834786 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.07018359 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.06909374 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.06760399 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06682246 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06428517 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.06057832 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.05993849 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.05936747 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05049425 |
| 123 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.04969563 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.04785527 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.04384394 |
| 126 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.03479894 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.02374246 |
| 128 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.0592128 |
| 129 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0499459 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | -0.0410114 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0328662 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | -0.0320148 |

